INTERNATIONAL SOCIETY FOR THE STUDY OF XENOBIOTICS

EIN: 222432063 501(c)(3) Science & Technology

WASHINGTON, DC

Total Revenue
$1,426,911
Total Expenses
$1,319,054
Total Assets
$1,415,457
Net Assets
$1,211,220
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1981
Legal Domicile
NJ
Principal Officer
ZOE FULLER
Phone
2023671160
Tax Period
2023-01-01 to 2023-12-31

INTERNATIONAL SOCIETY FOR THE STUDY OF XENOBIOTICS, founded in 1981, is a community nonprofit in the Science & Technology sector that reported $1.4M in total revenue in fiscal year 2023. Revenue surged 90% from the prior year, signaling strong growth momentum. Expenses of $1.3M left a modest 8% surplus.

Mission

ISSX IS AN INTERNATIONAL ASSOCIATION OF SCIENTISTS THAT PROMOTES THE UNDERSTANDING OF THE INTERACTIONS OF MEDICINES AND CHEMICALS WITH LIVING SYSTEMS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $66,915
Program Service Revenue $1,291,636
Investment Income $65,960
Other Revenue $2,400
TOTAL REVENUE $1,426,911

Expense Breakdown

Grants Paid $19,515
Salaries & Benefits $0
Fundraising Expenses $0
Program Expenses $1,041,614
Other Expenses $1,299,539
TOTAL EXPENSES $1,319,054

Year-over-Year Comparison

2023 2022 Change
Revenue $1,426,911 $752,876 +0.9%
Expenses $1,319,054 $833,569 +0.6%
Net Income $107,857 $-80,693 -2.3%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
10
Independent Members
10
Employees
N/A
Volunteers
11

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
5
$0
Total Directors
10
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
SCOTT OBACH PRESIDENT 4.00
Officer Director
$0 $0 $0
ALEKSANDRA GALETIN PRESIDENT-ELECT/SECRETARY 4.00
Officer Director
$0 $0 $0
SANDY PANG TREASURER 1.00
Officer Director
$0 $0 $0
MARY PAINE TREASURER-ELECT 1.00
Officer Director
$0 $0 $0
UWE FUHR COUNCIL MEMBER 1.00
Director
$0 $0 $0
KIYOMI ITO COUNCIL MEMBER 1.00
Director
$0 $0 $0
NINA ISOHERRANEN COUNCIL MEMBER 1.00
Director
$0 $0 $0
SIMONE SCHADT COUNCIL MEMBER 1.00
Director
$0 $0 $0
SWATI NAGAR COUNCIL MEMBER 1.00
Director
$0 $0 $0
HIROSHI YAMAZAKI COUNCIL MEMBER 1.00
Director
$0 $0 $0
ZOE FULLER EXECUTIVE DIRECTOR 20.00
Officer
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $1,426,911 $1,319,054 $1,415,457 $107,857
2022 $752,876 $833,569 $1,171,996 $-80,693
2021 $546,921 $468,520 $1,335,115 $78,401
2020 $230,042 $496,342 $1,248,500 $-266,300
2019 $899,615 $820,289 $1,485,305 $79,326
2018 $728,649 $893,709 $1,292,354 $-165,060
Explore More Nonprofits
Top 100 Nonprofits in District of Columbia Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare INTERNATIONAL SOCIETY FOR THE STUDY OF XENOBIOTICS with other nonprofits in District of Columbia and across the country.